Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 oct. 2023 09h01 HE | Source: Wohl & Fruchter LLP

MRTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Mirati Therapeutics, Inc. to Bristol Myers Squibb

MONSEY, N.Y., Oct. 20, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Mirati Therapeutics, Inc. (Nasdaq: MRTX) (“Mirati”) to...
17 oct. 2023 18h03 HE | Source: Moore Kuehn

Moore Kuehn Encourages SP, ORTX, MRTX, and SRT Investors to Contact Law Firm

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
20 avr. 2020 07h00 HE | Source: Fields Kupka & Shukurov LLP

INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Mirati Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims

NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Mirati Therapeutics, Inc....